Edward C. Li
Impact in
- Family Practice top 10%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Economic and Financial Impacts of Cancer 6
- Health Systems, Economic Evaluations, Quality of Life 4
- Pharmaceutical Economics and Policy 3
- Oncology 7
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- Lisa E. Davis (1 shared paper)Glen T. Schumock (8 shared papers)Linda M. Matusiak (7 shared papers)Robert J. Hunkler (6 shared papers)Lee C. Vermeulen (6 shared papers)Katie J. Suda (6 shared papers)JoAnn Stubbings (4 shared papers)Michelle D. Wiest (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)American Journal of Health-System Pharmacy (6 papers)Journal of the National Comprehensive Cancer Network (5 papers)Drug Discovery Today (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Edward C. Li
21 papers receiving 573 citations
Peers
Comparison fields: 5 of 84
- Family Practice 25
- Geriatrics and Gerontology 27
- Immunology 144
- Applied Microbiology and Biotechnology 10
- Oncology 117
Countries citing papers authored by Edward C. Li
This map shows the geographic impact of Edward C. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward C. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward C. Li more than expected).
Fields of papers citing papers by Edward C. Li
This network shows the impact of papers produced by Edward C. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward C. Li. The network helps show where Edward C. Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward C. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 111 | |
| 2 | 2003 | 93 | |
| 3 | 2016 | 80 | |
| 4 | 2014 | 58 | |
| 5 | 2010 | 56 | |
| 6 | 2017 | 41 | |
| 7 | 2015 | 31 | |
| 8 | 2010 | 30 | |
| 9 | 2018 | 28 | |
| 10 | 2015 | 23 | |
| 11 | 2010 | 16 | |
| 12 | 2018 | 11 | |
| 13 | 2015 | 7 | |
| 14 | 2010 | 6 | |
| 15 | 2019 | 3 | |
| 16 | 2010 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2012 | 1 |
About Edward C. Li
Edward C. Li is a scholar working on Economics and Econometrics, Oncology, Immunology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 603 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (6 papers), Biosimilars and Bioanalytical Methods (5 papers), Neutropenia and Cancer Infections (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Cancer Treatment and Pharmacology (3 papers), Pharmaceutical Economics and Policy (3 papers), Pharmaceutical studies and practices (3 papers) and Medication Adherence and Compliance (2 papers). The work is most often cited by research in Family Practice (25 citations), Geriatrics and Gerontology (27 citations), Immunology (144 citations), Applied Microbiology and Biotechnology (10 citations) and Oncology (117 citations). Edward C. Li has collaborated with scholars based in United States and Japan. Frequent co-authors include Lisa E. Davis, Glen T. Schumock, Linda M. Matusiak, Robert J. Hunkler, Lee C. Vermeulen, Katie J. Suda, JoAnn Stubbings, Michelle D. Wiest, James M. Hoffman and John S. Esterly. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Health-System Pharmacy, Journal of the National Comprehensive Cancer Network, Drug Discovery Today and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.